BIOMAT Database Logo BIOMAT Database Logo

The use of benzodiazepines in clinical practice. 1981

R I Shader, and D J Greenblatt

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D010076 Oxazepam A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia. Adumbran,Serax,Tazepam
D011222 Prazepam A benzodiazepine that is used in the treatment of ANXIETY DISORDERS. Centrax,Demetrin,Lysanxia,Mono Demetrin,Reapam
D002707 Chlordiazepoxide An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal. Methaminodiazepoxide,7-Chloro-2-methylamino-5-phenyl-3H-1,4-benzodiazepine-4-oxide,7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide,Chlordiazepoxide Hydrobromide,Chlordiazepoxide Hydrochloride,Chlordiazepoxide Monohydrochloride,Chlordiazepoxide Perchlorate,Chlozepid,Elenium,Librium,7 Chloro 2 methylamino 5 phenyl 3H 1,4 benzodiazepine 4 oxide,7 Chloro N methyl 5 phenyl 3H 1,4 benzodiazepin 2 amine 4 oxide,Hydrobromide, Chlordiazepoxide,Hydrochloride, Chlordiazepoxide,Monohydrochloride, Chlordiazepoxide,Perchlorate, Chlordiazepoxide
D003009 Clorazepate Dipotassium A water-soluble benzodiazepine derivative effective in the treatment of anxiety. It has also muscle relaxant and anticonvulsant actions. Chlorazepate,Dipotassium Chlorazepate,4306-CB,Clorazepate,Clorazepate Monopotassium,Clorazepic Acid,Tranxene,Tranxilium
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance

Related Publications

R I Shader, and D J Greenblatt
Reducing the use of benzodiazepines and cyclopyrrolones in clinical practice.
April 2006, Pharmacy practice,
R I Shader, and D J Greenblatt
[Should we continue to use benzodiazepines in clinical practice?].
June 2015, Recenti progressi in medicina,
R I Shader, and D J Greenblatt
The impact of benzodiazepines on clinical practice--considerations for therapeutic use.
August 1979, Minnesota medicine,
R I Shader, and D J Greenblatt
Reducing the use of benzodiazepines in general practice.
July 1994, BMJ (Clinical research ed.),
R I Shader, and D J Greenblatt
[Clinical use of benzodiazepines].
November 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
R I Shader, and D J Greenblatt
Discussion: using benzodiazepines in clinical practice.
January 2005, The Journal of clinical psychiatry,
R I Shader, and D J Greenblatt
Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice.
January 2015, Neuropsychiatric disease and treatment,
R I Shader, and D J Greenblatt
Benzodiazepines: clinical use patterns.
January 1980, NIDA research monograph,
R I Shader, and D J Greenblatt
Benzodiazepines in clinical practice: consideration of their long-term use and alternative agents.
January 2005, The Journal of clinical psychiatry,
R I Shader, and D J Greenblatt
Reduction in the use of benzodiazepines and cyclopyrrolones in general practice.
July 2008, Pharmacy practice,
Copied contents to your clipboard!